August 28, 2016 8:18 AM ET

Biotechnology

Company Overview of Envisia Therapeutics Inc.

Executive Profile

Eric W. Linsley CPA, MBA

Chief Financial Officer, Envisia Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 16 different industries.

See Board Relationships
----

Background

Mr. Eric W. Linsley, CPA, MBA, has been the Chief Financial Officer at Envisia Therapeutics Inc. since June 18, 2015. Mr. Linsley was a Managing Partner at Pappas Ventures, where he was directly responsible for investments that led to several very successful acquisitions and public offerings. Prior to joining Pappas Ventures in 2000, he served as the Chief Financial Officer and Vice President of TriPath Imaging Inc. Mr. Linsley played a key role in the three-way merger ...

Corporate Headquarters

419 Davis Drive
Morrisville, North Carolina 27560

United States

Phone: 919-973-1440
Fax: 919-973-1441

Board Members Memberships

Director
Member of the Board of Directors
Director
Chairman of The Board
2008-Present
Director, Chairman of Audit Committee and Member of Compensation, Nomination & Governance Committee

Education

MS
New York University
MBA
University of Pennsylvania - The Wharton School
BA
Trinity College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Envisia Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.